HIV Diagnostics Market Applications and Industry Overview Till 2022

10 July 2019: HIV Diagnostics Market is anticipated to reach USD 4.48 billion by 2022. The human immunodeficiency virus (HIV) leads to Acquired Immuno Deficiency Syndrome (AIDS). HIV attacks the immune system; thereby making one vulnerable to hoards of diseases. The factors that propel the growth of the HIV Diagnostics industry include growing number of blood transfusions and blood donations, prevalence of HIV/AIDS worldwide, assistance offered by point-of-care instruments & kits, and growing consciousness about HIV/AIDS and rising administration initiatives.

On the other hand, there are factors that may hamper the growth of the market including absence of acceptable testing labs, and restrictions of laboratory-based testing. HIV Diagnostics Market is anticipated to grow at a significant CAGR of 9.5% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request Free Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/hiv-diagnostics-market/request-sample

            HIV Diagnostics industry may be explored by Product type, end user, test type, and geography. The market may be explored by product type as Instruments, Software and Services, Consumables, Kits, Assay, and Reagents, and the other Consumables. The “Consumables” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 due to rising occurrence of HIV/AIDS, and growing enterprises from governments to fight HIV/AIDS.

The HIV Diagnostics Market could be explored based on end users as Hospitals, Diagnostics Laboratories, Home care settings, Blood banks, and Others (Gene bank, cell bank, pharma companies, and Biotechnology). The “Diagnostic Laboratories” segment led the market in 2016 and is anticipated to maintain its dominance by 2022 owing to technological developments of diagnostics laboratories, and high investment, and increasing consciousness of HIV/AIDS.

The market may be analyzed by test type as Tests for Viral Identification, Antibody Test, Viral Load Tests, Tests for Early Infant Diagnosis, and CD4 Tests. The “Antibody Tests” segment led the HIV Diagnostics industry in 2016 and is anticipated to maintain its dominance by 2022. The factors that attribute to the growth of market include consciousness about HIV, growing technological developments in HIV diagnosis.

North America accounted for the major share of the HIV Diagnostics Market Size in 2017 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing awareness about HIV, high occurrence and prevalence of HIV/AIDS, and rising administration initiatives and growing blood donations.

Some of the key players that fuel the growth of the HIV Diagnostics industry comprise Abbott Healthcare, Alere Inc., Brsitol-Myers Squibb, Abbvie Inc., Gilead Sciences, Janssen Therapeutics, Merck & Co. Inc, BD Biosciences, bioMerieux, VIIV Healthcare, Beckman Coulter, Sysmex, Partec, Qiagen, Apogee Flow Systems, Zyomyx Inc., Roche Diagnostics, Mylan Inc., Siemens Healthcare, and PointCare Technologies Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/hiv-diagnostics-market

Market Segment:

HIV Diagnostics Product Outlook (Revenue, USD Million, 2012 - 2022) 
    • Antibody Tests
        • HIV-1 Screening Tests
            • ELISA/EIA
            • Home Access Dried Blood Spot
            • Rapid Tests (Dot plot, Agglutination Tests)
        • HIV-1 Antibody Confirmatory Tests
            • Western Blot Test
            • Indirect Immunofluorescent Antibody Assay (IFA)
            • Line Immunoassay
            • Radio Immunoprecipitation Assay (RIPA)
        • HIV-2 & Group O Diagnostic Tests
            • Blood Antibody Tests
            • Dried Blood Spot (DBS) Test
            • Others and (Oral, Urine)
    • Viral Identification Assays
        • P24 Antigen Test
        • Qualitative PCR Tests
        • Viral Culture
    • CD4 Testing
    • Viral Load Testing
    • Early Infant Diagnostics

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Fluoroscopy Systems/Equipment Market Drivers and Growth Opportunities Forecast To 2025

5 July 2019: Global Fluoroscopy Systems/Equipment Market is anticipated to reach USD 4.74 billion by 2025. Fluoroscopy implies an imaging method that uses X-rays to Fluoroscopy is an imaging technique that uses X-rays to gain real-time moving images of the inner of an object. A fluoroscope permits a physician to understand the internal function and structure of a patient, so that the pushing action of the heart/the motion of allowing.

The factors that propel the growth of the Fluoroscopy Equipment industry include benefits of FPDs over image intensifiers, rising acceptance of adaptable imaging systems, reimbursement cuts for analog radiography systems, use of fluoroscopy in pain management, growing demand for minimally invasive methods, rising aged population, and the increasing occurrence of chronic diseases. On the other hand, the factors that may hamper the growth of the market include hazard of radiation from fluoroscopy methods. Fluoroscopy Systems/Equipment Market is anticipated to grow at a significant CAGR of 5.1% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/fluoroscopy-systems-equipment-market/request-sample

Fluoroscopy Systems/Equipment industry may be explored by product type, application, end users, and geography. The market may be explored by product type as C-arms may further include Full Size C-arms, Mini C-arms, and Fluoroscopy Devices. The “C-arms” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 due to wide applicability and high cost-efficiency in diverse arenas such as orthopedics, vascular surgery, traumatology, for intraoperative imaging, and others.

The key applications that could be explored in the Fluoroscopy Equipment Market include Cardiovascular, Orthopedic, Neurology, General Surgery, Pain Management & Trauma, Gastrointestinal, Urology, and Others. The “Cardiovascular” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 due to suitable strength of its energy projections has extended possibility for development over the years to come.

The fluoroscopy systems industry could be explored based on End users as Specialty Clinics, Hospitals, and Diagnostic Centers. The “Hospital” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 due to helpful substructure simplifies effective surgical methods, which mandates the adoption of C-arms and fluoroscopy devices, thus, subsequent in the higher share of hospitals.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/fluoroscopy-systems-equipment-market

North America accounted for the major share of the Fluoroscopy Systems Market Size in 2017 and will continue to lead in the forecast period. The factors that could be attributed to the growth includes growing occurrence of overuse rising prevalence of CVDs, sports injuries, and growing number of knee and hip replacement operations in the area are contributing to the huge share of North America.

Some of the key players that fuel the growth of the Fluoroscopy Systems/Equipment industry comprise GE Healthcare, Siemens AG, Shimadzu Corporation, Koninklijke Philips N.V., Ziehm Imaging GmbH, Hitachi Ltd., Toshiba Medical Systems Corporation, Hologic, Inc., Carestream Health, Inc., Agfa-Gevaert Group, Adani Systems Inc, and Lepu Medical Technology Co., Ltd. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Transplantation Market Revenue To Touch US$ 51.0 billion Forecast To 2025

2 July 2019: The global Transplantation Market is estimated to touch US$ 51.0 billion by the completion of the prediction period. The market was appreciated by US$ 23.5 Billion in the year 2016. Increasing demand for original fleshy tissue transplantation merchandises and body part transplantation for the treatment of organ disaster is a most important aspect backing in the direction of development of the market. The Transplantation market expected to develop at a CAGR of 9.1% for the duration of the prediction.

Ingestion of alcohol, misuse of medication, absence of keeping fit, and unnatural nutritional lifestyles are more or less most important reasons of organ disaster. Therefore, demand for transplantation merchandises likely to increase in the nearby future. The Transplantation industry on the source of Type of End Use Transplant centers, Hospitals, and Others. The subdivision of Hospitals detained the major stake of the market in the year 2016. Big number of organ and tissue transplant processes directed at hospitals such as they are most important action centers. Furthermore, arrival of hospitals by way of technologically advanced substructure additionally anticipated to trigger the progress of the market. Mainstream of these hospitals have admission to distinct records to check for obtainability of organs helping in speedy medicinal involvement.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/transplantation-market/request-sample

The Transplantation market on the source of Type of Application could span Tissue transplantation, Organ transplantation. The subdivision of Tissue transplantation was the biggest income-earning subdivision of the general market in the year 2016. This was because of replacement of veins, tendons, bones, skin, nerves, heart valves and cornea. These were maximum regularly done processes all over the world.

The increasing amount of burn and misfortune circumstances estimated to boost the demand for tissue products. As stated by CDC, in the year 2013, nearby 28.1 million people go to disaster department owing to accidental wounds. The Transplantation industry on the source of Type of Product could span Preservation solutions, Tissue products, Immunosuppressive drugs. The most significant products utilized for the transplantation of organ or tissue are tissue products, resistant suppressants, and protection solutions. The subdivision of tissue products was the maximum income making subdivision in the year 2016. The growing sum of transplantation processes for instance that of orthopedic soft tissues, heart valves, Cochlear and bone marrow is accrediting to the progress of the subdivision.

The Transplantation market on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage in these areas, for the duration of the prediction could span North America [U.S., Canada], Europe [Germany, U.K.], Asia Pacific [India, Japan, China], Latin America [Brazil, Mexico], Middle East & Africa [South Africa].

By the source of geography, North America led the Transplantation industry in the year 2016. It is estimated to continue with its supremacy during the course of prediction period. Strong amenities of healthcare and existence of numerous native big therapeutic and biotechnology equipment businesses, for example Stryker, Medtronic, Arthrex, Inc., Novartis AG, and Zimmer Biomet is assisting the development of the market.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/transplantation-market

The difference amid demand and source of organs, comprising heart, kidney, and liver for transplantation has augmented in the preceding period. On the other hand, administrations and NGOs of a number of republics are taking inventiveness to inspire public to contribute the organs and save lives. New-fangled strategies and instructions for organ contribution mark the contribution procedure additional clear as crystal and relaxed. In 2013, the Australian Government directed drive on nationwide improvement to upsurge organ contribution and transplant. This headed to an upsurge in the sum of organ contributions from the preceding time.

The market in the Asia Pacific is expected to develop by the maximum proportion for the duration of the prediction, due to the increasing investigation on stem cells to improve invitro soft tissue and organs along with increasing healthcare substructure in Asian nations for example Indonesia, Thailand, Philippines, and India.

The statement revises Trades in terms of intake of Transplantation in the market; particularly in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the field on international basis are Veloxis Pharmaceuticals, BioLifeSolutions, Inc., Stryker, Medtronic, Arthrex, Inc., Teva Pharmaceuticals, 21st Century Medicine, Novartis AG, Zimmer Biomet, and AbbVie, Inc.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Microtome Market Predicted To Growth at CAGR of 4.6% Till 2025

27 June 2019: Global Microtome Market is expected to reach USD 73.5 million by 2025. A microtome is powered tool exclusively used to cut very thin slices of biological material like plant or animal tissue for microscopic examinations. Special metal, diamond blades, or glass blades is used reliant on the type of specimen and the preferred thickness.

Microtomes are used in microscopy, mainly for the preparation of samples for observation under electron or light radiation. Steel blades are most probably used to make sections of animal or plant tissues. Laboratories uses microtome for various testing purposes. Microtome blades are extremely sharp, and need continuous re-sharpening to keep its sharpness and need to be held with caution. The Microtome Market is estimated to grow at a significant CAGR of 4.6% over the forecast period as the scope and its applications are rising enormously across the globe.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/microtome-market-size/request-sample

Microtome Market is segmented based on type, technology, blade type, application, end users, and region. Vibrating microtome, sledge microtome, infrared laser microtome, rotary microtome, and other types could be explored in Microtome in the forecast period. Manual, fully automated, and semi-automated are the technologies that could be explored in Microtome in the forecast period. Fully automated sector accounted for the largest market share of Microtome and is estimated to continue its dominance in the coming years.

There are several types of blade used in microtome are diamond microtome blade, metal microtome blade, and glass microtome blade that could be explored in forecast period. Metal blades are mainly made of steel and are used to slice the sections of animal and plant tissues for light microscopy histology. However, glass blades are exclusively used in electron microscopy and light microscopy applications.

The market may be categorized based on applications like cryosectioning technique, optical microscope, traditional histology technique, electron microscope, and others that could be explored in the forecast period. Electron microscopy is exclusively used to study stained thin sections about 60 to 100 nanometer of tissue and is termed as an ultramicrotome. In cryosectioning technique tissues are frizzed and cut in the frozen state using microtome-cryostat or freezing microtome. It is exclusively used to gain fast diagnosis in medical procedures. Research centers, hospitals, ambulatory surgical centers, and others are the end users that could be explored in Microtome in the forecast period.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/microtome-market-size

Globally, North America accounted for the substantial market share of Microtome and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be growing healthcare facilities reliant on enhanced cryostat microtome equipment. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The developing countries like India and China are the major consumers of Microtome in this region.

The key players of Microtome Market are Alltion, Amos scientific, AGD Biomedicals, Bright Instrument, MICROS Austria, Leica, Orion Medic, Thermo Fisher, Histo Line Laboratories, Medite, RMC Boeckeler, Auxilab, and Slee Medical. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/laboratory-equipment

Gas Chromatography Industry Segmentation, Scope, Trends and Applications by 2025

26 June 2019: The global Gas Chromatography (Gc) Market size is expected to value at USD 4.3 billion by 2025. The market is subject to witness a substantial growth due to the rising investments by private players and numerous governmental initiatives for development of modern in chromatography technologies. Other factors such as rising healthcare expenditure across developed economies along with increasing collaborations among various chromatography manufacturers and research laboratories are expected to drive market growth in the upcoming years.

Globally, the gas chromatography market is predicted to grow at CAGR of 6.4 % in forecast period, providing numerous opportunities for market players to invest in research and development in the market. Increasing investment by various regional government around the globe in the chromatography techniques for separating chemicals in a complex sample is expected to drive the growth of gas chromatography (GC) industry over the forecast period.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/gas-chromatography-gc-market/request-sample

Recent advancement in gas chromatography (GC) is attributed to the increasing investment for research & development from local governments in the North America region, thereby solidifying market position, in the recent years. For example, Government of Canada has undertaken various business development initiative to help organization such as NatrixSeparations, Inc. for development of innovative product and methodologies in the gas chromatography industry. Introduction of single use membrane-based chromatography products are driving demand of gas chromatography (GC) products from for large-scale pharmaceutical manufactures.

Application of the gas chromatography (GC) techniques in healthcare sector includes development & testing of various drugs and biotechnology applications. Some of the common application of the gas chromatography (GC) in pharmaceutical sector involves analytical research and development, quality assurance, quality control, and medicine formulations.

The gas chromatography (GC) market is broadly divided into three major types such as accessories & consumables, instruments, and reagents. The accessories and consumables is considered as one of the fastest growing segment in the market with substantial revenue generation in the last couple of years. Growing popularity of the accessories and consumables segment is attributed to constantly rising demand for gas chromatography (GC) accessories and their longer durability.

The accessories & consumables market segment is also divided into support fixtures, fittings & tubing, automatic sampler equipment, flow control accessories, and pressure regulator equipment. The column accessories or support fixture market sub-segment has witnessed substantial growth due to increasing adoption in the chromatography columns and various gas chromatography procedures including purification of proteins, biological medicine development for resin screening, development of prototype drug, desalting, and polishing.

Gas chromatography (GC), also called as vapor phase chromatography (VPC) or gas–liquid partition chromatography, is a kind of chromatography that is typically utilized for analyzing chemistry compound to separate and isolate the chemical substances by vaporizing without decomposition. Frequent application of the gas chromatography include measuring the purity of a given substance and isolating the various components from a mixture. Gas chromatography also helps to determine a particular class of compound.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/gas-chromatography-gc-market

The gas chromatography (GC) industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, increase in the venture capital funding and existence of well-established lab testing facilities in the region. Several developed European economies with promising financial & demographic landscape and growing focus towards chromatography-based research & studies are predicted to record comparatively higher CAGR in upcoming years.

Asia-Pacific region is predicted to hold major market share in the gas chromatography (GC) market with massive growth in forecast period. Countries such as India, China and Japan are leading the Asia-Pacific market with rising economic condition, growing scope for chromatography-based research and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the gas chromatography (GC) industry are GE Healthcare, Inc., Shimadzu Co., Thermo Fisher Scientific Incorporations, Agilent Technologies Ltd., W. R. Grace & Co., Bio-Rad Laboratories Incorporations, Restek Co., PerkinElmer Incorporations, Danaher Co., and DANI Instruments S.p.A.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Aptamers Industry Overview, Applications, Shares and Key Players Analysis by 2025

20 June 2019: Global Aptamers Market is anticipated to reach USD 8.91 billion by 2025. Aptamers implies peptide or oligonucleotides molecules that bind to target protein, nucleic acid, lipid molecules with a high specificity. Rapidly generated Aptamers are applied for specific detection, characterization, and inhibition of proteins. They have several characteristics and could be used as pharmaceutical leads, detection reagents, small molecules, efficient proteomic stages with antibodies, and the other aptamers.

The factors that propel the growth of the aptamers industry include strong trend of R&D savings in pharmaceutical and biotechnology industries, technological advancements, patent expiration of systematic development of ligands by exponential improvement technology (SELEX), and the low price and high productivity of aptamers in binding to large molecules as related to antibodies. On the other hand, there are factors that may hamper the growth of the market including low awareness of technology, and low-income countries. Aptamers Market is anticipated to grow at a significant CAGR of 28.2% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/aptamers-market/request-sample

Aptamers industry may be explored by type, technology, application, end user, and geography. The market may be explored by type as XNA-Based Aptamers, and DNA-Based Aptamers, RNA-Based Aptamers. The “DNA-based Aptamers” segment led the market in 2016 and is anticipated to maintain its dominance by 2025; even though XNA-based aptamers will increase at the highest CAGR between 2015 and 2025 owing to increase in demand for nucleic acid-based diagnostic therapeutics and kits across the globe.

The key applications that could be explored in the aptamers market include Research and Development, Therapeutics Development, Diagnostics, and Other Applications. The “Diagnostics” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 owing to introduction of novel diagnostic kits by major companies.

The aptamers industry could be explored based on end user as Contract Research Organizations, Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Other End Users. The “Academic And Government Research Institutes” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 followed by Biotechnology and Pharmaceutical Companies segment. The industry may be analyzed by technology as SELEX, and Other Technologies. The “Other Technologies” segment led the market in 2015 and is anticipated to maintain its dominance by 2025.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/aptamers-market

North America accounted for the major share of the aptamers market size in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing number of companies coupled with increasing R&D activities in this area, and continuous technological advancements in technologies, growing number of research laboratories and promising government initiatives.

Some of the key players that fuel the growth of the aptamers industry comprise Aptamer Group, Somalogic Inc., Aptamer Sciences Inc., Aptagen LLC, Noxxon Pharma, Base Pair Biotechnologies Inc., Vivonics Inc, etc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Market Segment:

Aptamers Types Outlook (Revenue, USD Million, 2014 - 2025)
    • Nucleic Acid
    • Peptide

Aptamers Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Diagnostics
    • Therapeutics
    • Research and Developments
    • Others

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology

Durable Medical Equipment Industry Shares, Growth Area, Business Overview and Specifications Forecast To 2024

12 June 2019: Global Durable Medical Equipment (DME) Market is estimated to reach USD 242.1 billion by 2024 owing to the increasing prevalence of chronic diseases that require long-term care. Durable medical equipment enable therapeutic benefits to a patient arising out of medical condition or illness. DME are prescribed by a physician to primarily serve medical purposes. They comprise wheelchairs, traction equipment, hospital beds, crutches, canes, ventilators, pressure mattresses, oxygen monitors, walkers, kidney machines, nebulizers, etc. which are reusable and can also be appropriately used at home.

Durable medical equipment can be either used alone or in combination with other equipment as well for safety, monitoring and diagnosis of disease. They proficiently assist in recovering health of large population across globe. The enhancement of medical equipment technologies has improved diagnosis and treatments of patients. Earlier, where the wheelchairs were operated manually, today powered wheelchairs are widely replacing the manual ones.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/durable-medical-equipment-dme-market/request-sample

Moreover, the growing demand for powered wheelchairs and the modernizations in equipment are projected to stimulate the growth of durable medical equipment (DME) industry in the years to come. Furthermore, the emergence of transfer lifts and mobility scooters in automated version is predicted to propel the growth of market significantly. These benefits are allowing people to avail more reliable healthcare systems and services which ultimately speed up their recovery chances.

However, chronic diseases like neurological diseases, cardiac diseases and cancers are considerably contributing to durable medical equipment (DME) market. Along with the growing prevalence of chronic diseases, diseases like diabetic foot, pressure ulcers & cancer that need long-term patient care and postoperative recovery are expected to contribute impressively to the market in the long-run.

As compared to the expensive hospital stay, home healthcare is a comparatively economic option for patients today. Therefore, patients prefer to opt post-operative recovery and long-term care at home itself. The growing demand for home healthcare services open opportunities for the DME market players to up sell and cross sell various equipment. Hence, the explosion of home healthcare services has contributed comprehensively to the durable medical equipment (DME) industry. Also, the increasing geriatric population base worldwide is predicted to propel the industry in the forecast period.

Durable medical equipment (DME) market is categorized on the basis of equipment type, end-user, and geography. On the basis of equipment type, the market is divided into bathroom safety devices, personal mobility devices, monitoring and therapeutic devices and medical furniture. Personal mobility devices segment is further divided into crutches & canes, wheelchairs, walkers, etc.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/durable-medical-equipment-dme-market

Medical furniture is further classified into medical beds, stretchers, lift chairs, mattress, etc. In terms of end-user, durable medical equipment (DME) industry is segmented as hospitals, ambulatory surgical centers, home care settings, long-term care centers, etc. Hospital segment is projected to hold majority share of the market owing to increasing number of hospitals and growing government initiatives for improving the health care segment.

Geographically, the durable medical equipment market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Asia Pacific is predicted to hold larger share of the market in the coming years due to the growing population in this region and rising preference for invasive and non-invasive monitoring devices like oxygen equipment and negative pressure wound therapy (NPWT) pumps.

Furthermore, the increasing number of investments by governments of emerging economies to improve the healthcare sector is also predicted to impact the market positively. The prominent durable medical equipment (DME) industry players comprise Baxter International Inc., Stryker Corporation, Medtronicplc. Becton, Drive DeVilbiss Healthcare, Dickinson and Company, Medline Industries, Inc., Invacare Corporation, Sunrise Medical (US) LLC, ResMed, Inc., Medical Depot Inc., and Hill-Rom Holdings, Inc.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Augmented Reality & Virtual Reality in Healthcare Industry Overview by 2019-2025: Industry Demand, Growth Rate and Future Prospect

12 June 2019: The global Augmented Reality (AR) & Virtual Reality (VR) In Healthcare Market size is expected to value at USD 5.1 billion by 2025. The augmented reality (AR) & virtual reality (VR) in healthcare industry is subject to witness a substantial growth due to the growing implementation of augmented reality (AR) and virtual reality (VR) in healthcare sector, increasing focus towards development of latest technologies, and recent infrastructural activities in healthcare sector.

Factors responsible for sustained market growth in the last few years include increasing focus on surgical simulations, diagnostic imaging, patient care management, rehabilitation, and pain management. Globally, the augmented reality & virtual reality in healthcare market is predicted to grow at CAGR of 29.1% in forecast period providing numerous opportunities for market players to invest in research and development in the augmented reality (AR) & virtual reality (VR) in healthcare industry.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/augmented-reality-ar-virtual-reality-vr-in-healthcare-market/request-sample

Increasing adoption of advanced technologies such as augmented reality (AR) & virtual reality (VR) are expected to revolutionize the healthcare sector due to their vast set of applications such as virtual training exercises for surgeons during complex surgeries, 3-D OPDs simulations, phobia buster in mental health treatment, and chronic pain management.

Virtual reality (VR) technology is widely adopted in Eye Movement Desensitization and Reprocessing (EMDR) therapy. Additionally, virtual reality (VR) technology aids in treatments such as autism therapy, depression therapy, cancer therapy and rehabilitation. Virtual reality (VR) technology based organ prototypes helps surgeons by preparing them for highly-sensitive and complex set of operations that require high accuracy, lessened complications and minimum trauma cases.

Growing popularity of augmented reality (AR) as a training and education tool is expected to widen the market reach in forecast period. Additionally, increasing use of augmented reality based apps include enhanced care for patients across the globe. Inception of highly advanced technology solutions such as vein visualization technology, which is implemented on a handheld scanner, helps healthcare professional, doctors and nurses to identify veins and valves accurately in time constrained environment to reduce pain during surgical procedures.

Various augmented reality (AR) android & iOS apps helps healthcare in aftercare of patients and aids elderly people to administer their medications intake. The rise in adoption of augmented reality (AR) & virtual reality (VR) is not only allows better patient care management but also offers real-time services, thus expanding market reach in the forecast period.

Augmented reality (AR) market segment has witness substantial growth over the forecast period owing to factors such as increasing preference toward AR as a training and education tool by healthcare professionals. Recent technological advancement and growing infrastructural activities in healthcare sector has paved way for increasing demand for augmented reality (AR) in healthcare IT industry.

Other factors attributing to the growth of AR market segment are assistance in patient care & management services, and medical imaging along with head-mounted displays. Growing popularity of augmented reality (AR) in fitness management due to development of numerous AR-based wellness and fitness apps, are transforming the fitness sector.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/augmented-reality-ar-virtual-reality-vr-in-healthcare-market

The augmented reality (AR) & virtual reality (VR) in healthcare market is divided by region such as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the adoption of latest technologies in medicine and pharmaceutical sector, growing prevalence of neurological & psychological disorders, and existence of well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the augmented reality & virtual reality in healthcare industry with massive growth in forecast period.

Countries such as India, China and Singapore are leading the Asia-Pacific market with rise in the prevalence of chronic diseases, and increase in number of internet & smartphone users, rise in government initiatives for adoption of digital & advanced technologies and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the augmented reality (AR) & virtual reality (VR) in healthcare market are Intuitive Surgical, Inc., CAE Healthcare Pvt. Ltd., 3D Systems Incorporations, Hologic Incorporations, and Laerdal Medical Corporations.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare-it

Cartilage Repair/Regeneration Market to Witness Enhanced Growth over Forecast Period Till 2025: Growth Prospect and Trends

The global Cartilage Repair/Regeneration Market size is expected to value at USD 6.7 billion by 2025. The market is subject to witness a substantial growth due to the increasing occurrence of bone and joint related diseases such as Osteoarthritis (OA) and arthritis, and recent technological advancements in cartilage regeneration. Growing geriatric population in across the globe, is susceptible towards Osteoarthritis (OA) and arthritis due to weakened bone structure. This in return is expected to fuel the growth of cartilage repair/regeneration industry over the forecast period.

Additionally, change in food patterns leading to obesity is considered as one of the prominent factor associated with market growth, in the recent years. Globally, the cartilage repair/regeneration market is predicted to grow at CAGR of 5.4% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/cartilage-repair-regeneration-market/request-sample

Growing prevalence of diabetes is considered as one of the critical factors driving the growth of cartilage regeneration industry, in recent years. Diabetes causes loss of cartilage leading to weakened bone structure which requires replacement of the cartilage or regeneration. Additionally, growing prevalence of obesity in various region across the globe is predicted to drive the growth of the market in upcoming years.

The American Heart Association (AHA) has reported that the global geriatric population is expected to account for approximately twenty percent of global population in next two decades. The geriatric population is extremely susceptible to chronic diseases and is predicted to be a critical factor in driving the demand for cartilage repair procedures, thus escalating market growth in the last few years.

Increase in number of road accidents and sports-related injuries across the globe, leading to bone and joint injuries is expected to amplify the demand for cartilage repair procedures in upcoming years. The recent technological advancements in cartilage repair and regeneration procedures coupled with inception of new techniques in the market is prompting adoption of cartilage repair and regeneration procedures in the recent years. Sports injuries are one of the prominent driver for increasing adoption of cartilage repair procedures. Sports such as bicycling, skating, and skateboarding are major sources of sports related injuries.

The cartilage repair market is divided into two major types based on treatment modalities such as cell-based treatment and non-cell-based treatment. Cell-based treatment is considered as one of the fastest growing segment in the market with substantial revenue generation in the last couple of years. Growing popularity of the cell-based treatments are expected to provide lucrative growth opportunities for industry players.

Development of autologous chondrocyte transplants in surgical treatment of damaged articular cartilage including chondral and osteo-chondral lesions has led to growing demand for cartilage repair and regeneration procedures. The non-cell-based segment has also witnessed substantial growth due to lower cost and superior outcomes. The non-cell-based segment is further divided into tissue scaffolds and cell-free composites.

The cartilage repair is classified into palliative and intrinsic repair stimulus. Introduction of advanced treatment methodologies such as visco-supplementation and debridement & lavage procedure are expected to drive demand of palliative repair treatments. Visco-supplement requires injecting of hyaluronic acid onto a joint to isolate and separate synovial fluid during surgical procedure for Osteoarthritis (OA) disorders.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/cartilage-repair-regeneration-market

The cartilage regeneration industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to rising occurrence of musculoskeletal diseases, growing patient’s pool, and changing lifestyle among individuals. Asia-Pacific region is predicted to hold major market share in the cartilage regeneration market with massive growth in forecast period.

Countries such as India, Australia, China and New Zealand are leading the Asia-Pacific market with growing geriatric population, increasing healthcare expenditure, and significant investment by leading industry players considering potential opportunities in the region. The key players in the cartilage repair/regeneration industry are Zimmer Biomet Holdings, Inc., Stryker Co., DePuySynthes, Inc., Smith & Nephew plc, Vericel Co., Osiris Therapeutics Incorporations, B. Braun Melsungen AG, Anika Therapeutics Incorporations, Arthrex, Incorporations, and Collagen Solutions Plc.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Radiation Oncology Market Research Till 2025: Analysis, Product Scope, Growth by CAGR and Shares

The global Radiation Oncology Market is estimated to touch US$ 10.1 Billion by the completion of the year 2025. The market was appreciated at US$ 5.7 Billion in the year 2016. Growing occurrence of cancer is the main issue accountable for sizeable development of the market above the prediction period. Technical progressions in radiotherapy caused in augmented acceptance of radiation oncology by way of main treatment track of cancer. Progress with respect to compact innovative radiotherapy preferences; for example Tomotherapy, Gama Knife, and Cyber Knife, add to this development. These progressive approaches stance slighter postoperative difficulties and sooner retrieval period.

The Radiation Oncology Market is estimated to develop at a CAGR of 6.5% for the duration of the prediction. Growing per head expenses on healthcare is likewise an essential macroeconomic issue motivating the development of the market. Furthermore, by way of the help of sympathetic government creativities and alertness, patients are not shy to choose for progressive treatment opportunities. For example, as per the information of World Bank Group per head expenses on health observed substantial development of over 55.0% between the years of 1995 to 2014.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/radiation-oncology-market/request-sample

The Radiation Oncology industry on the source of Type of Technology could span Systemic Beam Radiation Therapy, Brachytherapy [High-Dose Rate Brachytherapy, Low-Dose Rate Brachytherapy], External Beam Radiation Therapy [Volumetric Modulated Arc Therapy (VMAT), Proton Beam Therapy, Intensity Modulated Radiotherapy (IMRT), 3D Conformal Radiotherapy (3D CRT), Stereotactic Technology, Image-Guided Radiotherapy (IGRT)], and Others.

The Radiation Oncology market on the source of Type of Application could span Internal Beam Radiation Therapy [Penile Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Gynecological Cancer, and Others], External Beam Radiation Therapy [Colorectal Cancer, Lung Cancer, Prostate Cancer, Head and Neck Cancer, Breast Cancer, and Others].

The Radiation Oncology industry on the source of Type of Product could span Systemic Beam Radiation Therapy, Brachytherapy [Electronic Brachytherapy, See, Applicators and after loaders], External Beam Radiation Therapy [Proton Therapy {Synchrotron, Cyclotron}, Compact Advanced Radiotherapy Systems {Tomotherapy, Cyber Knife, Gamma Knife}, Electron-Emitting High-Energy Linear Accelerators {Linac}].

The Radiation Oncology market on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage could span North America [U.S.A, Canada], Europe [Germany, U.K.], Asia Pacific [Japan, China], Latin America [Brazil, Mexico], Middle East & Africa [South Africa].

By the source of geography, North America is the most important area in Radiation Oncology industry. North America controlled worldwide market for radiation oncology by way of grabbing above 40.0% stake in the year 2016. Accredit this supremacy to their progressive healthcare substructure, greater spending on healthcare and superior hard work on R&D.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/radiation-oncology-market

Yet, the degeneration in the source of isotopes has headed to a climb in the prices of these treatments, therefore subsequently, they are within the means of only a few people, and would necessitate extra spending. Furthermore, the consequences of insecurity regarding healthcare strategies & modifications in the U.S.A expected to convert into market subtleties decreasing funds in this vertical.

Conversely, Asia Pacific expected to develop by a rewarding proportion above the prediction period. Growth in the elderly inhabitants, suburbanization, and growing wealth in low and middle income nations similar to China and India have headed to a progression of radiation oncology industry in this area.

The statement revises Trades in terms of intake of Radiation Oncology in the market; particularly in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the field are Mallinckrodt Public Limited, Nor Dion (Canada) Inc., Mevion Medical Systems, Inc., C.R. Bard, Inc., Accuracy Incorporated, Varian Medical Systems, NTP, Iso Ray, Inc., Ion Beam Applications SA, and Elektra AB.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Infection Control Industry Product Type, Growth Prospect Mapping and Key Company Analysis by 2025

Global Infection Control Market is expected to reach USD 258.3 billion by 2025. Infection control is termed as a process to avert the spreading of communicable diseases in all healthcare settings like animal or human healthcare and hospitals facilities. The key role if infection control is to reduce the incidence of infectious diseases. These diseases are mainly caused by viruses or bacteria and can be spread by airborne transmission of infectious agents, human-to-human contact, human contact with an infected surface, and animal to human contact. The Infection Control Market is estimated to grow at a significant CAGR of 6.2% over the forecast period as the scope and its applications are rising enormously across the globe.

Growing occurrence of chronic diseases and hospital-acquired infections, high demand for disinfection and sterilization products among medical device manufacturers, pharmaceutical industries and hospitals, increasing focus on disinfection and food sterilization, and rising number of surgical procedures are documented as major factors of Infection Control Market that are estimated to enhance the growth in the years to come.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/infection-control-market/request-sample

However, strict regulations for service providers and equipment manufacturers and anxiety about the safety of reprocessed instruments are the factors that may restrain overall market growth in the coming years. Infection Control industry is segmented based on type, formulation, end users, and region.

Sterilization and disinfection are the types that could be explored in Infection Control in the forecast period. Sterilization wraps, disinfectant wipes, surgical drapes, disinfectant liquids, UV ray disinfectors, medical nonwovens, endoscope tracking systems, facemasks, flusher disinfectors, and other formulations could be explored in Infection Control in the forecast period.

The market may be categorized based on end users like food industry, hospitals & clinics, pharmaceutical companies, life sciences industry, medical device companies, and others could be explored in the forecast period. Hospital and clinics sector accounted for the substantial market share of Infection Control and is estimated to continue its dominance in the coming years. This may be because of rising rate of nosocomial infections and developing healthcare infrastructure in Asia Pacific.

Globally, North America accounted for the substantial market share of Infection Control and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be growing occurrence of chronic diseases, rising cost burden as growing geriatric population, increasing strength of industry competitiveness, and increasing number of surgeries performed in the U.S. The United States is a major consumer of Infection Control in the region.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/infection-control-market

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing occurrence of hospital acquired infections (HAIs), developing healthcare infrastructure, and growth in medical tourism in developing countries like India and China.

The key players of Infection Control Market are Pal International, STERIS, Advanced Sterilization Products, Getinge, 3M Company, Ecolab, Cantel Medical, Reckitt Benckiser, Sotera Health, Metrex Research, Matachana, Halyard Health, and Belimed AG. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Blood Culture Test Market Product Type, Growth Strategies and Size Estimations Forecast by 2025

Global Blood Culture Test Market is projected to reach USD 6.6 billion by 2025 owing to prevalence of blood infections and infectious diseases. Blood culture is a laboratory test wherein the patient’s blood is injected in bottles that contain culture media to determine the existence of infection-producing microorganisms like fungi or bacteria in the patient’s blood. It aims at confirming the existence of microorganisms in the blood, identifying the microbial etiology of the blood infection, helping to determine the infection source like endocarditis, and providing an organism for suspicion of testing and optimization of antimicrobial therapy. This test examines a sample of patient’s blood for yeast or bacteria that might be the root cause of infection. However, the growing demand for enhanced diagnostic techniques for the diagnosis of infectious diseases is expected to boost the blood culture tests market with a CAGR of 8.6%.

The blood infection, if left undetected, may lead to a severe and fatal condition called sepsis. The symptoms of bacteremia or initial bacterial infection are moderate or high fever, breathlessness, chills, muscular pain, palpitations, headache, tachycardia, and nausea. With the growth of infection, the indications also get serious; which may include dehydration, mottled skin, dizziness, confusion, drop in blood pressure, swelling, and organ failure.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/blood-culture-test-market/request-sample

Though blood samples are used for the detection of virus in blood, blood culture is essentially used to detect fungi or bacteria. Blood culture test is mostly done in combination with the other diagnostic tests like CBC (complete blood count) or the other chemical analysis. Different techniques like manual/conventional, automated and semi-automated methods could also be used to conduct blood culture test.

New product inventions, numerous regulatory approvals, rising sepsis conditions, growing number of infections in blood, increasing research & development of novel testing instruments and increasing number of adoptions for rapid diagnostic techniques are some factors that are bound to fuel blood culture test industry in the years to come. Additionally, the increasing elderly population and predominance of infectious disorders are the rest of key factors for the growth of the market.

However, costly automated instruments and shortage of skilled laboratory technicians are hampering the blood culture test market growth. Nevertheless, rising investments in Research & Development programs and increasing private and public healthcare expenditure are estimated to drive the market in the forecast period.

Blood culture test industry is categorized on the basis of method, product, application, end-user and geography. In terms of method, the market is divided into manual, conventional, and automated method. Based on product, the market is divided into instruments, consumables, and software & services.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/blood-culture-test-market

Consumables could be further classified into culture media type, kits, accessories, and reagents. In terms of application, blood culture tests industry is divided into fungemia, bacteremia, and mycobacterial. On the basis of end-users, the market is divided into academic research laboratories, independent diagnostic laboratories, hospital laboratories, etc.

Geographically, blood culture test market is segmented as North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Europe and North America are predicted to dominate the market due to high spending power over healthcare. Asia Pacific is also expected to hold larger share in near future owing to the growing demand for blood culture tests from emerging nations.

The prominent blood culture test industry players profiled here are Abbott Laboratories, Bruker Corporation, Bayer Healthcare, bioMérieux SA, Becton Dickinson, Siemens AG, Merck, Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher) and Roche Diagnostics.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Perfusion System Market Comprehensive Insights and Business Strategy Forecast Period by 2019-2025

The global Perfusion System Market size is expected to value at USD 183.8 million by 2025. The market is subject to witness a substantial growth due to the rising occurrence of organ failures, and spurring demand for transplantation procedures. Additionally, rising preference towards Machine Perfusion (MP) by clinics, and healthcare professionals across the globe is expected to boost market growth in coming years. Globally, the perfusion system market is predicted to grow at a CAGR of 8.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.

However, limited supply of resources is one of the prominent factor restraining market growth, in the recent years. Yet, recent innovation such as Machine Perfusion (MP) and Static Cold Storage (SCS) that are widely used as the preservation methods, are helping to curb this issue. Static Cold Storage (SCS) are increasingly adopted for preservation of organs, yet, they are incompetent to store high-risk organs. Emergence of Hypothermic Machine Perfusion (HMP) is considered as an effective solution to preserve high-risk organs.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/perfusion-system-market/request-sample

Growing demand of transplantation of human body parts is credited to rising prevalence of chronic diseases, leading to the growth of perfusion system industry. The rise in the geriatric population is attributed to the high-end demand of perfusion system, thus propelling growth of the market in recent years. Organ failure are more prominent in population above age of sixty. Additionally, rise in the number of organ failure is leading to the requirement of cost-effective solutions for organ preservation. Popularity of transplantation surgeries as a highly efficient treatment option for last-stage organ failure is on the rise. Higher success rates associated with these treatments in the recent years is estimated to boost the growth of perfusion system industry.

However, decline in number of organ donors are resulting in shortage in numerous medical facilities across the globe, thus hampering market growth to certain extent. Yet, shortage of organ donors has resulted in increased mortality rates, thus driving the demand for perfusion systems to improve organ feasibility. Increasing demand for preservation and transport facilities in cases such as last-stage organ failure and unavailability of the organ at particular medical facility, are expected to drive market progress in upcoming years. The recent technological advancement in healthcare industry are leading to the improved shelf life of organ, thus reducing mortality rates.

Hypothermic Machine Perfusion (HMP) is considered as fastest growing segment in the perfusion system market with substantial revenue generation in the last couple of years. Large number of benefits associated with early adoption of Hypothermic Machine Perfusion (HMP) such as kidney preservation alongside a cold storage, are offering required level safety and improved shelf life of an organ before transplantation procedure.

During surgical procedure such as kidney transplant surgery, it aids in aggregating patient survival rate and overall success rate of the surgical procedure performed worldwide. Hypothermic Machine Perfusion (HMP) is vital for the successful recovery of grafts before surgery. These systems helps in delivering oxygenated blood to the tissues of the human body.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/perfusion-system-market

The perfusion system industry is divided by region such as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown a high growth rate in recent years owing to the rise in the adoption of latest technologies in medical & pharmaceutical sector, increase in the demand for transplant surgeries, and existence of well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the perfusion system market with massive growth in forecast period.

Countries such as India, China and Japan are leading the Asia-Pacific market with rising prevalence of chronic diseases, growing demand for organ donation and significant investment by leading industry players considering potential growth opportunities in the region. The key players in the perfusion system industry are Xvivo Perfusion AB, Organ Assist BV. Organ Recovery Systems, Inc., Organ Transport Systems, Inc., Waters Medical Systems LLC, Paragonix Technologies Incorporations, TransMedics Incorporations, OrganOx Ltd., and Bridge to Life Ltd.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Joint Reconstruction Devices Market Scope, Production Status, Dynamics and Market Restraints Analysis Till 2025

The global Joint Reconstruction Devices Market size is expected to value at USD 30.4 billion by 2025. The market is subject to witness a substantial growth due to the increasing adoption of minimally invasive surgeries and recent technological advancement in the healthcare sector. Factors such as modernization of surgical devices and procedures coupled with increase in the health expenditure by local governments from developed economies across the globe are expected to amplify the growth of the market, in recent years.

Globally, the joint reconstruction devices market is predicted to grow at CAGR of 4.9% in forecast period, providing numerous opportunities for market players to invest in research and development in the market. Additionally, the rise in demand for minimally invasive diagnostic, innovative surgical methodologies, increase in occurrence of orthopedic conditions, and a large patient pool are some of the critical factors attributing to the growth of joint reconstruction devices industry, in recent years. Substantial rise in the elderly population in both developed and developing economies across the globe are driving the demand for joint reconstruction surgeries and devices.

Request Free Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/joint-reconstruction-devices-market/request-sample

Population above age of sixty are more prone to the orthopedic conditions due to weakened bone structure. Joint reconstruction is considered as one of the most crucial part of the global orthopedic devices industry. Some of the common causes for joint inflammation and damage include various arthritis conditions, osteoporosis, gout, and bone degenerative disorders. Growing prevalence of arthritis conditions and osteoporosis in young population is expected to fuel the growth of joint reconstruction devices industry in upcoming years.

Furthermore, changing lifestyle, varying food patterns and unhealthy dietary habits among large chunk of population are leading to rise in the prevalence of arthritis and osteoporosis conditions, thus driving the market growth further. Rise in number of initiatives undertaken by local governments and private bodies to create awareness among general population is anticipated to boost the market growth in upcoming years.

Recent innovation and research & development by industry players in joint-related conditions and therapeutic approaches are expected to amplify market opportunities over the forecast period. These factors are expected to augment the patient database in near future, leading to market expansion. Joint reconstruction contains a broad range of therapies such as physiotherapy, pain management, and various surgical procedures. Physiotherapyis considered as one of the fastest growing segment in the joint reconstruction devices market with substantial revenue generation in the last couple of years.

Growing popularity of the physiotherapy among patients in credited to its primary use in treatment of the joint conditions. Surgical procedure market segment has also witnessed substantial growth, in the recent years, due to its growing preference as a permanent cure for joint conditions. Also, rise in adoption of the minimally invasive surgeries is been witnessed in the last couple of years as well.

Browse Full Research Report with TOC@
https://www.millioninsights.com/industry-reports/joint-reconstruction-devices-market

Some of the primary causes for the need of joint reconstruction include aging, increase in the number of indoor accidents encountered by elderly people, leading to weakening of joints, pain inflammation, and limited movement. Joint are commonly covered with a protecting layer of cartilage that helps in swift movements of the bones. With growing age and excessive wear-and-tear causes leads to deprivation of cartilage, which makes joints weaker and vulnerable to develop cracks while falling.

The joint reconstruction devices industry is divided by region such as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in adoption of latest technologies in medical & pharmaceutical sector and existence of well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the joint reconstruction devices market with massive growth in forecast period.

Countries such as India, China and Japan are leading the Asia-Pacific market with favorable government policies, rise in the foreign investment due to numerous initiatives by local governments, and significant investment by leading industry players considering potential opportunities in the region. The key players in the joint reconstruction devices industry are Medtronic plc, Nuvasive Incorporations, Zimmer BiometHoldings, Inc., Stryker Co., DePuySynthes Companies, Aesculap Implant Systems, Inc. Smith & Nephew plc, CONMED Co., and DJO Global Incorporations.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Medical Tapes and Bandages Market Top Companies, Drivers and Size Forecast To 2025

Global Medical Tapes and Bandages Market is anticipated to reach USD 10.97 billion by 2025. Pressure sensitive adhesive tapes that are employed to assist bandage or the other wound dressings are known as “Medical Tapes”. On the other hand, Medical bandages could be defined as a cotton gauge cloth helpful for supporting splint or surgical dressing. Medical tapes and bandages are mainly used to uphold moistness at place of dressing. They offer bacterial & mechanical safety to the wound, and promote wound healing.

The factors that propel the development of the market include increasing incidence of chronic wounds, rising number of surgeries, and increasing aged population. On the other hand, there are factors that may hamper the growth of the market including increasing consciousness about progressive wound care. Medical Tapes and Bandages Market is anticipated to grow at a significant CAGR of 5.10% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request Free Sample Copy of this Market Research Report@ https://www.millioninsights.com/industry-reports/medical-tapes-bandages-market/request-sample

Medical Tapes and Bandages industry may be explored by product type, application, end users, and geography. The market by product type could span Plastic Tape, Paper Tape, Fabric Tape, and Other Tapes).Medical Bandages could span Adhesive Bandage, Elastic Bandage, Gauze Bandage, Cohesive, and Other Bandages. The “Medical Bandages” segment led the Medical Tapes and Bandages industry in 2016 and is anticipated to maintain its dominance by 2025 owing to an increase in medical situations that require surgical intervention, increasing aged population, and high number of surgical procedures.

The key applications that could be explored in the market include Traumatic and Laceration Wounds, Ulcers, Surgical Wounds, Sport Injuries, Burns, and Other Wounds. The “Ulcer Treatments” sector led the Medical Tapes and Bandages Market in 2016 and is anticipated to maintain its dominance by 2025 due to increasing number of patients with ulcers owing to development in the diabetic populace.

The market could be explored based on end users as Homecare Setting, Hospitals, Clinics, and Ambulatory Surgical Centers. The “Hospitals” sector led the Medical Tapes and Bandages industry in 2016 and is anticipated to maintain its dominance by 2025 due to huge number of surgical methods executed in hospitals.

Browse Full Market Research Report with TOC@
https://www.millioninsights.com/industry-reports/medical-tapes-bandages-market

Asia-Pacific accounted for the major share of the Medical Tapes and Bandages Market Size in 2016 and will continue to lead in the forthcoming period. The factors that could be attributed to the growth include increasing patient consciousness regarding wound infections and diseases, and rapidly growing aged populace in the regions.

Some of the key players that fuel the development of the Medical Tapes and Bandages industry comprise Medtronic, Smith & Nephew PLC,3M,Derma Sciences Inc, B. Braun Melsungen AG, Johnson & Johnson, Paul Hartmann AG, Medline Industries Inc., Molnlycke Healthcare Inc., and Cardinal Health Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Drugs of Abuse Testing Services Industry Type, Opportunities and Scope Till 2025

Global Drug of Abuse Testing Services Market is anticipated to reach USD 2.9 billion by 2025. Drugs of abuse testing implies discovery of one or more prescribed or illegal substances in the blood, urine, hair, sweat, saliva. The procedure is carried out with the help of several methods like Chromatography, Rapid Testing, and Immunoassays Analyzers. Immunoassays Analyzers is the equipment that supports biochemical tests to sense substances or quantify specific proteins. The procedure takes place with the support of antibodies or antigens that perform the test.

The factors that propel the growth of the Drug of Abuse Testing Services industry include new product & service launches, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals, and increasing consumption of drugs & alcohol. On the other hand, there are factors that may hamper the development of the market; including growing drug-related mortality, growing demand for drug of abuse treatment, and rising government entities. Drugs of Abuse Testing Services Market is anticipated to grow at a significant CAGR in the forthcoming period as the scope, product types, and its applications are increasing across the globe.

Request Free Sample Copy of this Market Research Report@ https://www.millioninsights.com/industry-reports/drugs-abuse-testing-services-market/request-sample

The market could be explored by sample type, testing type, drug type, end user, and geography. Drugs of Abuse Testing Services industry may be analyzed by sample type as Saliva, Breath, Urine, Blood, and Hair and Sweat. The “Urine” segment led the market in 2016 and is anticipated to maintain its dominance by 2025.

Drug of Abuse Testing Services Market may be explored by Testing Type as Work Place Screening, Criminal Justice Testing, and Pain Management Testing. The “Workplace Testing” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 owing to increasing safety concerns in the workplace coupled with compulsion of drug screening. Drug of Abuse Testing Services industry may be analyzed by drug type as Cannabis, Alcohol, Cocaine, Opioids, LSD, and Amphetamine. The industry may be analyzed by end user as Diagnostic laboratories, Hospitals, Forensic Laboratories, and On-the-spot Testing.

Browse Full Market Research Report with TOC@
https://www.millioninsights.com/industry-reports/drugs-abuse-testing-services-market

North America accounted for the major share of the Drug of Abuse Testing Services Market Size in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing demand for rapid testing devices in North America and improved use of drug testing facilities in investigational procedures. North America is followed by Europe.

Some of the key players that fuel the growth of the Drug of Abuse Testing Services industry comprise Siemens Healthineers, Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., F. Laboratory Corporation of America Holdings, Drägerwerk AG & Co. KGaA, Abbott Laboratories, and Danaher Corporation (Beckman Coulter, Inc). The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare